dupilumab,spesolimab
sanofi,regeneron,boehringer ingelheim
['spesolimab', 'psoriasis', 'dupilumab', 'derm']
the translational revolution in inflammatory skin diseases: pustular psoriasis, il-36 inflammatory cycle, spesolimab, dupilumab and other novel treatments explored by dr. mark lebwohl at #aad2023 
Official Twitter account for the Department of Dermatology @mountsinainyc. Leaders in dermatological treatment, care, research and education.